Background/Aims: (CRNDE) contributes to the proliferation and migration of tumors. However, its molecular mechanism underlying gastric cancer remains unknown. In the present study, we investigated whether CRNDE was involved in the development of colorectal cancer via the binding of microRNA (miR)-217 with transcription factor 7-like 2 (TCF7L2) to enhance the Wnt signaling pathway. Methods: Quantitative polymerase chain reaction was used to detect CRNDE, miR-217 and TCF7L2 in colorectal cancer tissues and cells. The CCK-8 assay, wound healing assay, and Transwell assay were used to detect cell proliferation, migration and invasion, respectively. Western blotting and luciferase activity assays were used to identify CRNDE and TCF7L2 as one of the direct targets of miR-217. The activity of the Wnt/ -catenin signaling -catenin and TCF7L2 was analyzed by western blotting and confocal microscopy. Results: In this study, miR-217 in colorectal cancer tissue and colorectal cancer cells. The dual luciferase reporter analysis showed that miR-217 is bound to CRNDE and TCF7L2 and negatively regulate their in vitro and in vivo and the inhibitions were both completely blocked after miR-217 inhibition -catenin
Introduction
Colorectal cancer (CRC) is a common cause of cancer death in the world due to late tumor presentation and rapid progression [1] [2] [3] [4] . There are approximately 14.1 million worldwide new cancer cases and 8.2 million cancer deaths in 2012 [4] . In economically developing countries, CRC is becoming more prevalent, especially in China [5, 6] . However, the molecular mechanisms underlying CRC progression remain largely unclear.
More than 90% of the DNA sequence is actively transcribed, but only 2% encodes protein; thus, most transcripts are as non-coding RNAs (ncRNAs) [7, 8] , some of which are involved in malignant transformation and/or cancer progression [9] [10] [11] [12] . Based on size, noncoding RNAs are divided into two groups: small ncRNAs, such as microRNAs (miRNAs, ~22 nucleotides), which regulate gene expression and are involved in tumorigenesis [13] [14] [15] [16] [17] [18] [19] [20] , and long non-coding RNAs (lncRNAs, greater than 200 nt). LncRNAs are involved in various physiological and cellular processes such as development, growth, cell cycle progression, in colorectal cancer and was found to be located on chromosome 16, which is important in the proliferation, migration, and invasion of colorectal tumor cells [24] [25] [26] [27] [28] . Nonetheless, little is known regarding the biological role of CNRDE in the process of colorectal cancer.
Several studies have shown that lncRNAs may interact with miRNAs and mutually modulate their expressions [29] . They may function as competing endogenous RNAs (ceRNAs) with miRNAs and subsequently regulate protein coding gene expression by the with miRNAs is involved in cancer pathogenesis [31] [32] [33] . This interaction provides new insight into cancer biology.
Here we show that high expression of CRNDE is negatively correlated with low expression of miR-217 in colorectal cancer tissue and colorectal cancer cells. Furthermore, CRNDE down-regulation inhibited the cell proliferation, migration and invasion in vitro and in vivo and the inhibitions were both completely blocked after miR-217 inhibition or TCF7L2 overexpression. Dual luciferase reporter analysis showed that miR-217 is directly bound to immunostaining and western blotting showed that the activity of Wnt/ -catenin signaling is inhibited by CRNDE down-regulation and rescued by TCF7L2 over-expression. These results suggest that CRNDE is involved in the development of colorectal cancer cells via miR-217 mediated Wnt/ -catenin regulation.
Materials and Methods

Specimen collection
Twenty-one pairs of colorectal specimens, including twenty-one human colorectal adenocarcinoma cancer tissues and twenty-eight adjacent tissues, were obtained from the Fudan University Shanghai Cancer Center. The detailed clinicopathological characteristics of the recruited patients are summarized in Table S1 , for all online suppl. material, see www.karger.com/doi/ 10.1159/000475941. This study was approved by the Ethics Committee of Fudan University Shanghai Cancer Center.
The lentiviral vector used as the negative control sequence (Con) contained the non-silencing sequence and was used as the infection control for lentiviral vector production and cell infection. Lentiviral vectors were produced by the transient transfection of HEK293 cells according to standard protocols as previously transfection was accomplished with 1,800 µL of DNA solution containing 10 µg of lv-shCRNDE, 10 µg of ® -mediated transfection. ® by packaged lentiviral production. Parallel noninfected HCT-116 and Caco2 cells were simultaneously observed. Cells were cultured in normal growth medium for 72 h after infection. RNAi-NC infection, as a control, was performed as described above. Cells were subsequently propagated in selection medium containing puromycin.
Cell viability assays
The cell viability was monitored using the Cell Counting Kit-8 (CCK8) assay (Dojindo Molecular Technologies, Kumamoto, Japan) according to the manufacturer's protocol. All the experiments were repeated at least three times.
Wound healing assays
HCT-116 cells were scraped with a sterile micropipette tip. In the next step, wounded monolayers were washed with phosphate buffer solution (PBS) to remove cell debris. At two time points, the distance between two edges of the wound was calculated at three different positions. In addition, HCT-116 cells were measured at 24 h. The migration rate was calculated as follows: (% at 0 h) = (D 0 -D T )/D 0 × 100%, where D 0 refers to the distance measured at 0 h, and D T refers to the distance measured at 24 h.
Transwell invasion assays
Analyses of tumor cell migration and invasion were carried out using Transwell ® chambers (8 µm; 5 HCT-116 and Caco2 cells in serum-free medium was collected and seeded in an upper chamber containing a non-Matrigel-coated membrane. Next, 500 µL of medium containing 15% FBS was added to the lower chamber. For the invasion assay, the chambers were coated with incubator with 5% CO 2 . Non-invading cells in the upper chamber were removed with a cotton swab, and were counted by using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The results were averaged among three independent experiments. 
Western blotting
lysis buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2.5 EDTA mM, 50 mM NaF, 0.1 mM Na 4 P 2 O 7 , 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mM DTT, 0.02% (v/v), protease cocktail (Sigma-Aldrich), 1% (v/v) Triton X-100, and 10% (v/v) glycerol. The homogenates were centrifuged twice at 20,000 g and the supernatants were saved as total proteins. The protein concentrations were determined by the bicinchoninic acid assay (BCA) method. Equal amounts of proteins were separated by sodium dodecyl (Ab8245; Abcam) antibodies. The immunoreaction was visualized using an enhanced chemiluminescent
Real-time PCR Analysis
Total RNA from cells was isolated with the Ultraspec (Biotecx, Houston, TX, USA) according to the manufacturer's instructions. Quantitative PCR analysis was performed using an ABI PRISM 7900 Sequence Detector System (Applied Biosystems, Foster City, CA, USA) as previously described. For the determination of gene expression, the Assay-on-Demand ™ system (Applied Biosystems) was used. The transcript levels determination were performed at least in triplicate, and the levels of gene expression were calculated using
Luciferase reporter assay
Renilla luciferase vector into HCT-116, Caco2 and HCT-15 cells in the presence of either the miR-217 mimic or scramble. A dual luciferase assay (Promega) was performed 48 h after transfection. The experiments were performed independently in triplicate.
encoding Renilla luciferase was purchased from Promega (Madison, WI, USA). Cells were seeded onto 12-well plates at 6 × 10 4 0.02 µg of pRL-TK using Lipofectamine ® 2000 (Invitrogen) following the manufacturer's protocol. The cells were collected 24 h post-transfection. After lysed and centrifuged, and the supernatant was used for luciferase activity was normalized to Renilla luciferase activity and was expressed as the relative luciferase activity. 
Results
CRNDE expression is up-regulated in colorectal cancer tissues and cell lines.
the CRNDE expression level in colorectal cancer tissue was 3.24-fold that of matched normal tissue (p= 0.026). Based on the expression of CRNDE, these cases were divided into a high CRNDE expression group (n = 10) and a low expression group (n = 11), based on a CRNDE/ in clinical stage III and IV patients than in clinical stage I and II patients (p = 0.026), although no associations were found between CRNDE expression and other clinicopathological features (see supplementary material, Table S2 ). Compared with NCM460 cells, a normal human colon mucosal epithelial cell line, it was observed that CRNDE was differentially high expressed in a series of cultured colorectal cancer cell lines (LoVo, SW48, DLD-1, Caco2 and HCT-15), with the highest expression in HCT-116 cells, followed by that in Caco2 cells (Fig.  1B) . CRNDE expression was almost 26.9-fold and 23.7-fold higher respectively in HCT-116 and Caco2 cells than that in NCM460 cells. This observation allowed the use of HCT-116 and Caco2 cells as the representative cell lines that were further cultured for subsequent analyses. Collectively, these data suggest that CRNDE was up-regulated in primary colorectal cancer samples.
CRNDE down-regulation inhibits cell proliferation, migration and invasion in colorectal cancer cells in vitro and impairs the tumorigenicity and metastasis in vivo
To demonstrate the role of CRNDE in colorectal cancer cell proliferation, migration, and Furthermore, the effect of CRNDE knockdown on colorectal cancer cells tumorigenicity and metastasis in vivo were evaluated in HCT-116 and Caco2 xenograft models. The growth of the xenografted tumors was measured for 30 days. As shown in Figure 2E , the neoplastic nodules (spontaneous metastases) on each lung was counted and evaluated at knockdown xenografts. Collectively, these observations suggested that CRNDE was involved in the regulation of cell proliferation, migration and invasion in vitro and in vivo.
miR-217 directly binds to CRNDE, and the expression levels of miR-217 and CRNDE exhibit an inverse correlation in colorectal cancer tissues and cell lines
To determine the mechanism of action for CRNDE in Colorectal cancer development, we predicted that CRNDE might be associated with the miR-217 binding site (130-135bp) according to a bioinformatics database (RNA hybrid) (Fig. 3A) . Furthermore, a dual luciferase gene reporter assay showed that CRNDE could bind to miR-217 at the predicted binding sites. As shown in Fig. 3B , miR-217 mimic could inhibit the luciferase activity in CRNDE-WT group. But it has no effect in CRNDE-Mut group. These results indicated that miR-217 binds to the transcript position (130-135) of CRNDE. Furthermore, quantitative RT-PCR results demonstrated that miR-217 expression was up-regulated in colorectal cancer tissues (Fig.  3C ) and cell lines (Fig. 3D and Fig. S2A, see supplementary material) . We also found the Caco2 (Fig. 3E ) and HCT-15 cells (see supplementary material, Fig. S2B ). Therefore, these results suggest that there is a reciprocal interaction and negative regulation between CRNDE and miR-217.
miR-217 inhibition completely blocks the effect of CRNDE down-regulation on colorectal cancer cells
To understand the role of miR-217 increasing after CRNDE down-regulation in HCT-116, Caco2 and HCT-15, we decreased the expression of miR-217 by the miR-217 inhibitor.
217 expression was obviously inhibited (Fig. 4A and Fig. S3, see supplementary material) . Amazingly, the down-regulation of miR-217 completely blocked the effect of CRNDE down-regulation with increased cell viability (Fig. 4B) , cell migration capability (Fig. 4C) , and invasion capability (Fig. 4D ) of the HCT-116 and Caco2 cells. These results suggested the increasing level of miR-217 is obviously crucial to the inhibition of cell proliferation, migration and invasion after CRNDE down-regulation.
miR-217 directly target TCF7L2 and negatively regulate its expression
Our data suggested that miR-217 could be a crucial role in the inhibition of cell proliferation, migration and invasion after CRNDE down-regulation in HCT-116 and Caco2 cells. However, its downstream regulation is unknown. To further determine the regulatory role of CRNDE concerning miR-217 and its biological function, we further explored the correlation with the expression of CRNDE. These results suggest that miR-217 can target TCF7L2 and negatively regulate its expression in colorectal cancer cells.
TCF7L2 overexpression completely blocks the effect of CRNDE down-regulation on colorectal cancer cells
To determine the role of TCF7L2 in CRNDE down-regulation in HCT-116 and Caco2 cells, we up-regulated the expression of TCF7L2 by transfection a plasmid of pLVX-TCF7L2 effect of up-regulation of TCF7L2 is highly like miR-217 inhibition which completely blocks the effect of CRNDE down-regulation with increased cell viability (Fig. 6B and Fig. S5A , see supplementary material), cell migration capability (Fig. 6C) , and invasion capability (Fig. 6D ) of the HCT-116 and Caco2 cells. Taken together, these data indicated that TCF7L2 repression acts as a direct and functional target of miR-217 and contributes to the inhibition of cell proliferation, migration and invasion after CRNDE down-regulation.
CRNDE down-regulation inhibits colorectal cancer cells proliferation, migration and invasion via miR-217 mediated TCF7L2 repression and subsequent inhibition of Wnt/ -catenin signaling pathway
As TCF7L2 is an effector of the Wnt/ -catenin signaling pathway [34] , it is possible that the inhibition of colorectal cell proliferation, migration and invasion induced by CRNDE results indicated that the activity of Wnt/ CRNDE down-regulation and completely rescued by TCF7L2 overexpression (Fig. 7A and Fig.  S5B, see supplementary material) . Western blotting showed a marked decrease in nuclear -catenin, the major effector of Wnt signaling, in the CRNDE down-regulated cells relative to that of the parental cells (Fig. 7B) . TCF7L2 overexpression did not affect the content of nuclear -catenin alone but abolished the reduction of nuclear -catenin in the CRNDE downregulation group. Furthermore, the subcellular localization of -catenin was visualized by confocal microscopy (Fig. 7C ) that was mostly accumulated in the nucleus in the control group. After CRNDE down-regulation in the HCT-116 and Caco2 cells, -catenin was mostly the nuclear translocation of -catenin in the CRNDE down-regulation group. Collectively, these data strongly support the hypothesis suggested that CRNDE contributes to the cell proliferation, migration and invasion of colorectal cancer cells via negative regulation of miR-217 mediated TCF7L2 repression and subsequent inhibition of Wnt/ -catenin signaling pathway (Fig. 8) .
Discussion metastasis and proliferation regulation by interacting with miRNA, such as HOTAIR (HOX study, we found that CRNDE was highly expressed in colorectal cancer tissue and colorectal cancer cells, while miR-217 expression was low in colorectal cancer tissue and colorectal cancer cells. Moreover, CRNDE down-regulation inhibited the proliferation, migration, invasion of CRCs in vitro and in vivo and could also regulates the activity of Wnt/ -catenin RNAs may crosstalk with each other through shared miRNAs, thereby modulating the bioavailability of miRNAs for their targets and imposing various levels of posttranscriptional regulation. Based on their functions, miRNAs could be grouped as onco-miRs (oncogene-like microRNAs) and tumor suppressor-miRs (tumor suppressor like microRNA) [29, 32, [35] [36] [37] [38] . Herein, we showed that miR-217 was a novel tumor suppressormiR in colorectal cancer that inhibited cancer progression via directly targeting the TCF7L2 gene and subsequent inhibiting the Wnt/ suppressor in hepatocellular carcinoma [39] . The expression of miR-217 was much lower in highly invasive cell lines and metastatic tissues. In vitro and in vivo studies showed that miR-217 could directly target E2F3 and consequently inhibit tumor invasion [39] . However, in another study of pancreatic ductal adenocarcinoma, miR-217 was reported to inhibit the functions of KRAS, the loss of which enhanced tumor proliferation [40] . By contrast, miR-217 was demonstrated to act as an oncogene in aggressive human B-cell lymphomas, and it down-regulated the expression of a DNA damage response and repair gene network and, in turn, stabilized . Considering these reported differences in a few types of cancers, we hypothesize that the role of miR-217 might be cancer species dependent and further investigations are required.
The transcription factor 7-like 2 (TCF7L2) gene, previously called TCF-4, may affect signaling pathway [42] . Dysregulation of genes plays a role in carcinogenesis and is especially well documented for colorectal cancer [43] [44] [45] [46] . It is well known that the Wnt/ -catenin signaling pathway is constitutively active in most tumor cells [47, 48] . TCF7L2, one member of the Wnt signaling pathway, represents a central factor in metabolism, stress responses, cell differentiation/proliferation, and cell death [34] . Here we show that the expression level of nuclear -catenin protein and Wnt/ -catenin signaling activity were reversed the decrease in cell viability and increase in cell migration and invasion in the cells -catenin signaling was inhibited by CRNDE down-regulation via suppressing TCF7L2 in colorectal cancer.
In conclusion, the present study reported that CRNDE is involved in the development of colorectal cancer cells via miR-217 mediated Wnt/ -catenin regulation. CRNDE may be a potential miRNA inhibitor, which needs to be considered in oncotherapy that focuses on metastasis inhibition.
